Wasting syndromes can be produced by thymectomizing newborn mice soon after birth (7) or by treating newborn mice with allogeneic lymphoid cells (1) , multiple doses of certain bacterins or bacterial products (3) (4) (5) , cortisol acetate (12) , and certain infectious agents (2, 13) . These syndromes are characterized by marked wasting, diarrhea, high mortality, and a diminution of lymphoid cells and immunological competence. Studies in germfree mice negate the concept that all forms of wasting disease, despite similarities in pathology, have a similar pathogenesis. Thus, typical wasting with high mortality did not occur in young germfree mice after neonatal thymectomy (6, 14) , injection with sterile bacterins (4), or injection with cortisol acetate (8) , suggesting an infectious process engendered by an impairment of the immunological competence of the treated host. In contrast, a highly fatal wasting syndrome did develop in young germ-free mice treated with allogeneic lymphoid cells (6, 11) .
Reilly and co-workers (10) have recently reported that the repeated injection of estradiol into newborn mice induces a wasting disease characterized by a failure to gain weight normally, a hunched posture and mincing gait, altered thymic and splenic histology, impaired immunological capacity, and high mortality. Inclusion of oxytetracycline in the drinking water was associated with greater survival and weight gain; however, bacteriological techniques failed to reveal an etiological agent (10) . Thus, it was of interest to determine the effect of the germ-free state on the development of this wasting syndrome.
We used conventionally reared (CR) and germfree (GF) Manor Swiss mice, reared as previously described (9) . All experimental groups contained at least 25 mice. The GF mice are not claimed to be virus-free; however, antibodies specific for the following viruses were not detected in the sera of germ-free mice; mouse adenovirus, mouse hepatitis, Kilham When CR and GF mice, less than 24-hr old at the initial injection, were injected on the low-dose schedule, both groups exhibited a hunched posture, high-stepping gait, failure to gain weight normally, and a runted appearance. Both CR and GF mice showed a disparity in weight and growth by the seventh injection when compared with their controls. By the 11th injection, control mice weighed nearly twice as much as the estradioltreated mice. Importantly, a marked difference in survival was observed between the CR and GF mice (Table 1) . Death was not observed in the GF mice treated with estradiol during a 50-day observation period, whereas 89% of the CR mice treated with estradiol died during this period. With the high-dose schedule, the onset of symptoms was earlier and symptoms were more severe. In addition, considerable mortality was observed in GF mice (Table 1) , although mortality was still higher in CR mice than in GF mice.
The timing of the initial estradiol injection was critical. Wasting disease was regularly produced in mice given a series of injections starting during the first day of life. As the age at initial injection was increased, however, the incidence of wasting decreased.
Reilly and co-workers (10) suggest that estra-VOL. 99, 1969 diol impairs the function of the thymus at a time when it is crucial for the normal development of the peripheral lymphoid organs in mice, and lymphoid hypoplasia, lymphopenia, immunological deficiency, and wasting ensue. Our observations concerning the critical timing of the initial injection and increased survival in GF mice support this belief. In addition, we observed that the primary hemagglutinin and hemolysin response to sheep erythrocytes was impaired in CR and GF mice treated neonatally with estradiol.
The failure to consistently isolate bacteria from the tissues of wasting mice does not rule out an involvement of microorganisms in the pathogenesis of this wasting disease; microbial products, perhaps endotoxin (5), or viruses may be involved. The decreased mortality observed in GF neonates after estradiol administration strongly suggests that microorganisms, or their products, play an important role in the terminal event, death.
It is significant that severe signs of wasting in GF mice given the low-dose schedule and severe signs of wasting with high mortality in GF mice given the high-dose schedule of estradiol were observed. Thus, in addition to an effect on the lymphoid apparatus and immunological competence, the repeated injection of large doses of estradiol into young mice must cause other severe physiological changes.
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